{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:12:10Z","timestamp":1791612730606,"version":"4.3.4"},"reference-count":39,"publisher":"American Diabetes Association","issue":"9","license":[{"start":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T00:00:00Z","timestamp":1566259200000},"content-version":"vor","delay-in-days":40,"URL":"http:\/\/www.diabetesjournals.org\/content\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,9,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>Whether diabetes mellitus (DM) increases risk of gastric cancer (GC) remains controversial because of inadequate adjustments for important risk factors, including Helicobacter pylori (HP) infection status, concomitant medication use, and cancer site. We investigated whether type 2 DM increased risk of GC in patients after they received treatment for HP infection.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>This was a territory-wide cohort study of patients aged \u226545 years who had received clarithromycin-based triple therapy for HP infection between 2003 and 2012 in Hong Kong. Data were retrieved from a public electronic health database. Observation started from receipt of therapy for HP infection to GC diagnosis, death, or the end of the study (December 2015). Exclusion criteria included type 1 DM, GC diagnosed within the 1st year of HP therapy, prior GC or gastrectomy, and retreatment for HP infection. The adjusted hazard ratio (aHR) of GC with type 2 DM was calculated by using a Cox model that adjusted for 20 covariates (age, sex, comorbidities, and medications) through propensity score regression.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>During a median follow-up of 7.1 years (interquartile range 4.8\u20139.3 years), 153 of 46,460 patients (0.33%) developed GC at a median age of 72.4 years. Type 2 DM was associated with an increased risk of GC (aHR 1.73 [95% CI 1.08\u20132.79]). Stratified analysis showed an increase in risk for cardia cancer only (aHR 3.40 [95% CI 1.45\u20137.97]) and in those with suboptimal DM control (time-weighted mean HbA1c \u22656.0% [42 mmol\/mol]; aHR 1.68 [95% CI 1.07\u20132.63]).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Type 2 DM is associated with an increased risk of GC among patients in whom HP was eradicated, in particular gastric cardia cancer and in those with suboptimal DM control.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc19-0437","type":"journal-article","created":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T22:36:30Z","timestamp":1562884590000},"page":"1769-1775","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":55,"title":["Diabetes Increases Risk of Gastric Cancer After <i>Helicobacter pylori<\/i> Eradication: A Territory-Wide Study With Propensity Score Analysis"],"prefix":"10.2337","volume":"42","author":[{"given":"Ka Shing","family":"Cheung","sequence":"first","affiliation":[{"name":"Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther W.","family":"Chan","sequence":"additional","affiliation":[{"name":"Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijia","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai Kay","family":"Seto","sequence":"additional","affiliation":[{"name":"Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian C.K.","family":"Wong","sequence":"additional","affiliation":[{"name":"Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong"},{"name":"UCL School of Pharmacy, University College London, London, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5993-1059","authenticated-orcid":false,"given":"Wai K.","family":"Leung","sequence":"additional","affiliation":[{"name":"Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2019,7,11]]},"reference":[{"key":"2022031300523774200_B1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"2022031300523774200_B2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/gut.49.3.347","article-title":"Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts","volume":"49","author":"Helicobacter and Cancer Collaborative Group","year":"2001","journal-title":"Gut"},{"key":"2022031300523774200_B3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4251\/wjgo.v10.i5.115","article-title":"Risk of gastric cancer development after eradication of Helicobacter pylori","volume":"10","author":"Cheung","year":"2018","journal-title":"World J Gastrointest Oncol"},{"key":"2022031300523774200_B4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10120-003-0265-0","article-title":"The future of gastric cancer prevention","volume":"7","author":"Correa","year":"2004","journal-title":"Gastric Cancer"},{"key":"2022031300523774200_B5","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1053\/j.gastro.2016.01.028","article-title":"Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis","volume":"150","author":"Lee","year":"2016","journal-title":"Gastroenterology"},{"key":"2022031300523774200_B6","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrc2536","article-title":"Insulin and insulin-like growth factor signalling in neoplasia","volume":"8","author":"Pollak","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"2022031300523774200_B7","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1200\/JCO.1997.15.2.826","article-title":"Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma","volume":"15","author":"Tanigawa","year":"1997","journal-title":"J Clin Oncol"},{"key":"2022031300523774200_B8","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1172\/JCI112295","article-title":"High glucose induces DNA damage in cultured human endothelial cells","volume":"77","author":"Lorenzi","year":"1986","journal-title":"J Clin Invest"},{"key":"2022031300523774200_B9","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0140-6736(96)90013-6","article-title":"Oxidative damage to DNA in diabetes mellitus","volume":"347","author":"Dandona","year":"1996","journal-title":"Lancet"},{"key":"2022031300523774200_B10","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3748\/wjg.v19.i6.936","article-title":"Pre-existing diabetes mellitus increases the risk of gastric cancer: a meta-analysis","volume":"19","author":"Yoon","year":"2013","journal-title":"World J Gastroenterol"},{"key":"2022031300523774200_B11","doi-asserted-by":"crossref","first-page":"44881","DOI":"10.18632\/oncotarget.16487","article-title":"Diabetes mellitus and the risk of gastric cancer: a meta-analysis of cohort studies","volume":"8","author":"Miao","year":"2017","journal-title":"Oncotarget"},{"key":"2022031300523774200_B12","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1053\/j.gastro.2008.12.045","article-title":"Hyperglycemia increases risk of gastric cancer posed by Helicobacter pylori infection: a population-based cohort study","volume":"136","author":"Ikeda","year":"2009","journal-title":"Gastroenterology"},{"key":"2022031300523774200_B13","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/jnci\/djx267","article-title":"Aspirin and risk of gastric cancer after Helicobacter pylori eradication: a territory-wide study","volume":"110","author":"Cheung","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"2022031300523774200_B14","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1093\/annonc\/mdt150","article-title":"Statins are associated with reduced risk of gastric cancer: a systematic review and meta-analysis","volume":"24","author":"Singh","year":"2013","journal-title":"Ann Oncol"},{"key":"2022031300523774200_B15","doi-asserted-by":"crossref","first-page":"55622","DOI":"10.18632\/oncotarget.16973","article-title":"Association between metformin and the risk of gastric cancer in patients with type 2 diabetes mellitus: a meta-analysis of cohort studies","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget"},{"key":"2022031300523774200_B16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/gutjnl-2017-314605","article-title":"Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study","volume":"67","author":"Cheung","year":"2018","journal-title":"Gut"},{"key":"2022031300523774200_B17","doi-asserted-by":"crossref","DOI":"10.1177\/1756284819834511","article-title":"Long-term use of proton-pump inhibitors and risk of gastric cancer: a review of the current evidence","volume":"12","author":"Cheung","year":"2019","journal-title":"Therap Adv Gastroenterol"},{"key":"2022031300523774200_B18","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1111\/jgh.13329","article-title":"Diabetic biomarkers and the risk of proximal or distal gastric cancer","volume":"31","author":"Kim","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"2022031300523774200_B19","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1158\/1055-9965.EPI-10-1244","article-title":"Prospective study of self-reported diabetes and risk of upper gastrointestinal cancers","volume":"20","author":"Lin","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022031300523774200_B20","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1001\/jama.2015.10029","article-title":"Prevalence of and trends in diabetes among adults in the United States, 1988-2012","volume":"314","author":"Menke","year":"2015","journal-title":"JAMA"},{"key":"2022031300523774200_B21","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-317714","article-title":"Statins reduce the progression of non-advanced adenomas to colorectal cancer: a postcolonoscopy study in 187 897 patients","author":"Cheung","year":"2019","journal-title":"Gut"},{"key":"2022031300523774200_B22","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2017.43","article-title":"Epidemiology and natural history of primary biliary cholangitis in the Chinese: a territory-based study in Hong Kong between 2000 and 2015","volume":"8","author":"Cheung","year":"2017","journal-title":"Clin Transl Gastroenterol"},{"key":"2022031300523774200_B23","doi-asserted-by":"crossref","DOI":"10.1111\/jgh.14674","article-title":"Epidemiology, characteristics, and survival of post-colonoscopy colorectal cancer in Asia: a population-based study","author":"Cheung","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"2022031300523774200_B24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000094040","article-title":"Update on clarithromycin resistance in Helicobacter pylori in Hong Kong and its effect on clarithromycin-based triple therapy","volume":"73","author":"Gu","year":"2006","journal-title":"Digestion"},{"key":"2022031300523774200_B25","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1523-5378.2009.00722.x","article-title":"Clarithromycin-amoxycillin-containing triple therapy: a valid empirical first-line treatment for Helicobacter pylori eradication in Hong Kong","volume":"14","author":"Hung","year":"2009","journal-title":"Helicobacter"},{"key":"2022031300523774200_B26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1742-7843.2006.pto_293.x","article-title":"Indications for propensity scores and review of their use in pharmacoepidemiology","volume":"98","author":"Glynn","year":"2006","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2022031300523774200_B27","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.brat.2017.01.005","article-title":"A practical guide to propensity score analysis for applied clinical research","volume":"98","author":"Lee","year":"2017","journal-title":"Behav Res Ther"},{"key":"2022031300523774200_B28","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"2022031300523774200_B29","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ijc.25362","article-title":"Risk of cancer in a large cohort of U.S. veterans with diabetes","volume":"128","author":"Atchison","year":"2011","journal-title":"Int J Cancer"},{"key":"2022031300523774200_B30","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s10552-010-9515-8","article-title":"Diabetes and risk of incident cancer: a large population-based cohort study in Israel","volume":"21","author":"Chodick","year":"2010","journal-title":"Cancer Causes Control"},{"key":"2022031300523774200_B31","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/sj.bjc.6605240","article-title":"A cohort study of the risk of cancer associated with type 2 diabetes","volume":"101","author":"Ogunleye","year":"2009","journal-title":"Br J Cancer"},{"key":"2022031300523774200_B32","first-page":"493","article-title":"Fasting serum glucose level and gastric cancer risk in a nested case-control study","volume":"39","author":"Jun","year":"2006","journal-title":"J Prev Med Public Health"},{"key":"2022031300523774200_B33","first-page":"253","article-title":"Site-specific cancer risk due to diabetes mellitus history: evidence from the Japan Collaborative Cohort (JACC) Study","volume":"7","author":"Khan","year":"2006","journal-title":"Asian Pac J Cancer Prev"},{"key":"2022031300523774200_B34","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00125-006-0207-6","article-title":"Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria","volume":"49","author":"Rapp","year":"2006","journal-title":"Diabetologia"},{"key":"2022031300523774200_B35","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/ijc.21600","article-title":"Diabetes mellitus and cancer risk in a population-based case-control study among men from Montreal, Canada","volume":"118","author":"Rousseau","year":"2006","journal-title":"Int J Cancer"},{"key":"2022031300523774200_B36","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/bjc.1994.427","article-title":"A case-control study of diabetes mellitus and cancer risk","volume":"70","author":"La Vecchia","year":"1994","journal-title":"Br J Cancer"},{"key":"2022031300523774200_B37","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0021-9681(85)90139-0","article-title":"Diabetes mellitus and cancer risk: a multisite case-control study","volume":"38","author":"O\u2019Mara","year":"1985","journal-title":"J Chronic Dis"},{"key":"2022031300523774200_B38","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/jnci\/djy144","article-title":"Metformin use and gastric cancer risk in diabetic patients after Helicobacter pylori eradication","volume":"111","author":"Cheung","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"2022031300523774200_B39","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1046\/j.1365-2036.2000.00758.x","article-title":"High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis","volume":"14","author":"Hamada","year":"2000","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/42\/9\/1769\/529807\/dc190437.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/42\/9\/1769\/529807\/dc190437.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T04:22:44Z","timestamp":1647145364000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/42\/9\/1769\/36236\/Diabetes-Increases-Risk-of-Gastric-Cancer-After"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,11]]},"references-count":39,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,7,11]]},"published-print":{"date-parts":[[2019,9,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc19-0437","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,11]]}}}